We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. IL-23 inhibitors were associated with the lowest ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window People mounting ...
Researchers determine the clinical and demographic risk factors of paradoxical eczema as well as the overall incidence and biologic-class-specific risk factors and incidence of paradoxical eczema in ...
Data point to the potential of JNJ-2113 as a first-in-class drug candidate in multiple IL-23 driven-diseases Highlights of the data presented on JNJ-2113 include the following: JNJ-2113 is a ...
Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the treatment of plaque psoriasis. We conducted a phase 3, double-blind, randomized, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Approximately 60% to 85% of patients who develop ...
Although interleukin-23 has been implicated in the pathogenesis of asthma, in this randomized, controlled trial involving adults with severe asthma, inhibition of interleukin-23 signaling with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results